Travere Therapeutics Inc (TVTX) — Cash Flow-to-Debt Ratio
Travere Therapeutics Inc (TVTX) has a Cash Flow-to-Debt Ratio of -0.09x as of March 2026, meaning its operating cash flow of $-40.37 Million could theoretically repay 0% of its total liabilities ($456.46 Million) in one year. Explore how much of Travere Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Travere Therapeutics Inc Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Travere Therapeutics Inc across 16 annual periods. Also explore TVTX asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Travere Therapeutics Inc (2010–2025)
Year-by-year debt coverage analysis for Travere Therapeutics Inc. For market capitalisation and broader financial context, see Travere Therapeutics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | $37.78 Million | $490.36 Million | ▲ +117.4% |
| 2024 | -0.44x | $-237.47 Million | $535.05 Million | ▲ +6.8% |
| 2023 | -0.48x | $-280.02 Million | $588.10 Million | ▼ -61.0% |
| 2022 | -0.30x | $-186.29 Million | $629.73 Million | ▼ -849.0% |
| 2021 | -0.03x | $-14.79 Million | $474.52 Million | ▲ +71.1% |
| 2020 | -0.11x | $-42.74 Million | $396.23 Million | ▲ +28.9% |
| 2019 | -0.15x | $-58.21 Million | $383.60 Million | ▼ -137.7% |
| 2018 | -0.06x | $-24.96 Million | $390.91 Million | ▼ -296.0% |
| 2017 | 0.03x | $7.40 Million | $227.21 Million | ▲ +544.1% |
| 2016 | -0.01x | $-1.60 Million | $217.51 Million | ▼ -181.4% |
| 2015 | 0.00x | $-554.00K | $212.43 Million | ▲ +99.0% |
| 2014 | -0.27x | $-45.85 Million | $172.72 Million | ▲ +41.4% |
| 2013 | -0.45x | $-17.59 Million | $38.81 Million | ▲ +4.0% |
| 2012 | -0.47x | $-2.74 Million | $5.80 Million | ▼ -64418.1% |
| 2011 | 0.00x | $-49.00 | $66.99K | ▲ +93.2% |
| 2010 | -0.01x | $-689.00 | $64.21K | — |